Abstract: An example method includes displaying, by a display screen of an image capturing device, a preview of an image representing a field of view of the image capturing device. The method includes determining a region of interest in the preview. The method includes transitioning the image capturing device from a normal mode of operation to a zoomed mode of operation. The zoomed mode of operation includes: determining, based on sensor data collected by a sensor associated with the image capturing device, a motion trajectory for the region of interest, and based on the determined motion trajectory, generating an adjusted preview representing zoomed portion of the field of view. The adjusted preview displays the region of interest at or near a center of the zoomed portion. The method includes providing the adjusted preview of the portion of the field of view.

Abstract: An example method includes receiving, by a computing device, a plurality of image frames. The method also includes determining, by the computing device, one or more objects of interest within the plurality of image frames, wherein the determining is based on saliency heat maps indicative of the one or more objects of interest. The method further includes determining at least one seam corresponding to at least one pair of successive image frames of the plurality of image frames, wherein the determining of the at least one seam is based on respective weights associated with the one or more objects of interest. The method additionally includes stitching together, by the computing device and based on the at least one seam, the at least one pair of successive image frames to generate a panorama image.

Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods of treating arthritogenic alphavirus infection and methods of screening.

Abstract: The present disclosure is directed to compositions and methods of treating arthritogenic alphavirus infection. Compositions include a fusion protein comprising an Fc region, a first Mxra8 region, and a second Mxra8 region, wherein the fusion protein reduces inflammation and infection by an arthritogenic alphavirus. Methods include administering the fusion protein to a mammalian or non-mammalian subject to reduce or inhibit alphavirus infection.

Abstract: Compositions and methods for treating a viral infection may comprise use of a viral recognition-site inhibiting agent composition. A viral recognition-site inhibiting agent composition of the present disclosure may substantially inhibit, reduce, or block virus bind to the LDLRAD3 host receptor and reduces the infectivity of a virus for a host cell. A method of treating a viral infection may comprise administering a composition comprising a viral recognition-site inhibiting agent of the present disclosure, to a subject and reducing the infectivity of the virus for a host cell of the subject. The compositions may be administered via intranasal or systemic administration to treat or prevent a viral infection, for example an alphavirus infection.

Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods of treating arthritogenic alphavirus infection and methods of screening.